23 March 2023 in The Lancet
6 June 2023 in International Journal of Health Policy and Management
Background: Non-communicable diseases (NCDs) kill 41 million people a year. The products and services of unhealthy commodity industries (UCIs) such as tobacco, alcohol, ultra-processed foods and beverages and gambling are responsible for much of this health burden. While effective public health policies are available to address this, UCIs have consistently sought to stop governments and global organisations adopting such policies through what is known as corporate political activity (CPA). We aimed to contribute to the study of CPA and development of effective counter-measures by formulating a model and evidence-informed taxonomies of UCI political activity. Methods: We used five complementary methods: critical interpretive synthesis of the conceptual CPA literature; brief interviews; expert co-author knowledge; stakeholder workshops; testing against the literature. Results: We found 11 original conceptualisations of CPA; four had been used by other researchers and reported in 24 additional review papers. Combining an interpretive synthesis of all these papers and feedback from users, we developed two taxonomies – one on framing strategies and one on action strategies. The former identified three frames (policy actors, problem, and solutions) and the latter six strategies (access and influence policy-making, use the law, manufacture support for industry, shape evidence to manufacture doubt, displace, and usurp public health, manage reputations to industry’s advantage). We also offer an analysis of the strengths and weaknesses of UCI strategies and a model that situates industry CPA in the wider social, political, and economic context. Conclusion: Our work confirms the similarity of CPA across UCIs and demonstrates its extensive and multi-faceted nature, the disproportionate power of corporations in policy spaces and the unacceptable conflicts of interest that characterise their engagement with policy-making. We suggest that industry CPA is recognised as a corruption of democracy, not an element of participatory democracy. Our taxonomies and model provide a starting point for developing effective solutions.
6 July 2023 in Health Research Policy and Systems
Context: Participatory systems mapping is increasingly used to gain insight into the complex systems surrounding non-communicable diseases (NCDs) and their risk factors. Objectives: To identify and synthesize studies that used participatory systems mapping in the context of non-communicable diseases. Design: Scoping review. Eligibility criteria: Peer-reviewed studies published between 2000 and 2022. Study selection: Studies that focused on NCDs and/or related risk factors, and included participants at any stage of their system’s mapping process, were included. Categories for analysis: The main categories for analysis were: (1) problem definition and goal-setting, (2) participant involvement, (3) structure of the mapping process, (4) validation of the systems map, and (5) evaluation of the mapping process. Results: We identified 57 studies that used participatory systems mapping for a variety of purposes, including to inform or evaluate policies or interventions and to identify potential leverage points within a system. The number of participants ranged from 6 to 590. While policymakers and professionals were the stakeholder groups most often included, some studies described significant added value from including marginalized communities. There was a general lack of formal evaluation in most studies. However, reported benefits related mostly to individual and group learning, whereas limitations described included a lack of concrete actions following from systems mapping exercises. Conclusions: Based on the findings of this review, we argue that research using participatory systems mapping would benefit from considering three different but intertwined actions: explicitly considering how different participants and the power imbalances between them may influence the participatory process, considering how the results from a systems mapping exercise may effectively inform policy or translate into action, and including and reporting on evaluation and outcomes of the process, wherever possible.
5 August 2024 in Food Security
There is growing recognition that global food system transformation requires a fundamental shift in norms, perspectives and structural inclusion and exclusion of different actors in decision-making spaces. As multistakeholder governance approaches become increasingly common, significant concerns have been raised about their ability to deliver such change. Such concerns are based on case study findings repeatedly highlighting their susceptibility to corporate capture. This study goes beyond individual case studies, examining global multi-stakeholder initiatives (MSIs) whose stated aim is to drive a healthier and more sustainable food system. It identified and categorised actors within these MSIs, drawing on social network analysis to provide insights into actor centrality, power structures, and how this might impact MSIs’ potential to drive transformative change. Thirty global MSIs were included in our sample, including a total of 813 actors. Most actors were based in high-income countries (HIC) (n = 548, 67%). The private sector (n = 365, 45%) was the most represented actor category, comprising transnational corporations (TNCs) (n = 127) and numerous others representing their interests. NGOs, affected communities and low- and middle-income country actors remain underrepresented. The central involvement of TNCs which rely on the production and sale of unhealthy and unsustainable commodities represents a clear conflict of interest to the stated objectives of the MSIs. These findings lend weight to concerns that MSIs may reflect rather than challenge existing power structures, thus serving to maintain the status quo. This indicates a need to critically examine the use of multistakeholder governance approaches and their ability to drive global food system transformation.
3 March 2021 in International Journal of Health Policy and Management
KHKristine Rasmussen Hone
Background: This systematic review aims to estimate the proportion of medical schools and teaching hospitals with conflicts of interest (COI) policies for health research and education, to describe the provisions included in the policies and their impact on research outputs and educational quality or content. Methods: Experimental and observational studies reporting at least one of the above mentioned aims were included irrespective of language, publication type or geographical setting. MEDLINE, Scopus, Embase and the Cochrane Methodology Register were searched from inception to March 2020. Methodological study quality was assessed using an amended version of the Joanna Briggs Institute’s checklist for prevalence studies. Results: Twenty-two cross-sectional studies were included; all were conducted in high-income countries. Of these, 20 studies estimated the prevalence of COI policies, which ranged from 5% to 100% (median: 85%). Twenty studies assessed the provisions included in COI policies with different assessment methods. Of these, nine analysed the strength of the content of medical schools’ COI policies using various assessment tools that looked at a range of policy domains. The mean standardised summary score of policy strength ranged from 2% to 73% (median: 30%), with a low score indicating a weak policy. North American institutions more frequently had COI policies and their content was rated as stronger than policies from European institutions. None of the included studies assessed the impact of COI policies on research outputs or educational quality or content. Conclusion: Prevalence of COI policies at medical schools and teaching hospitals varied greatly in high-income countries. No studies estimated the prevalence of policies in low to middle-income countries. The content of COI policies varied widely and while most European institutions ranked poorly, in North America more medical schools had strong policies. No studies were identified on impact of COI policies on research outputs and educational quality or content.